Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
1 Receptor
54%
BD1047
9%
Beta-tubulin
9%
Calcein
9%
Cell Death
27%
Cell Survival
9%
Co-treatment
9%
ERK2
18%
Ethidium homodimer-1
9%
Extracellular Signal-regulated Kinase 1/2
100%
Free Media
9%
Immunoblotting
9%
Immunofluorescence Staining
9%
Immunopanning
9%
Insults
100%
Ischemia
100%
MEK1
18%
Mitogen-activated Protein Kinase
9%
Neuroprotection
18%
Neuroprotective
9%
Neuroprotective Effect
9%
Ocular Neurodegenerative Disease
9%
Oxygen-glucose Deprivation/reoxygenation (OGD/R)
72%
PD098059
18%
Pentazocine
63%
Phosphorylation
9%
Primary Retinal Ganglion Cells
27%
Protective Effect
9%
Receptor 1
9%
Receptor Agonist
9%
Receptor Antagonist
9%
Retinal Ganglion Cells
100%
Sigma-1 Receptor
100%
Sprague-Dawley Rats
9%
Therapeutic Target
9%
Medicine and Dentistry
2 (2 Amino 3 Methoxyphenyl)chromone
14%
Beta Tubulin
7%
Calcein
7%
Cell Death
21%
Cell Survival
7%
Degenerative Disease
7%
Ethidium
7%
Ganglion
100%
Glucose
64%
Homodimer
7%
Immunoblotting
7%
Immunofluorescence
7%
Ischemia
100%
Mitogen Activated Protein Kinase 3
100%
Mitogen-Activated Protein Kinase
7%
Neuroprotection
14%
Neuroprotective Agent
14%
Pentazocine
50%
phosphorylation
7%
Receptor
35%
Receptor Antagonist
7%
Sigma 1 Opiate Receptor
100%
Therapeutic Target
7%
Neuroscience
Beta Tubulin
7%
Cell Death
21%
Cell Survival
7%
Glucose
64%
Immunoblotting
7%
Immunofluorescence
7%
Ischemia
100%
Mitogen Activated Protein Kinase 3
100%
Mitogen-Activated Protein Kinase
7%
Neurodegenerative Disorder
7%
Neuroprotection
14%
Neuroprotective Agent
14%
Pentazocine
50%
phosphorylation
7%
Receptor
28%
Receptor Agonists
7%
Receptor Antagonist
7%
Retinal Ganglion Cell
100%
Sigma 1 Opiate Receptor
100%
Staining Technique
14%